PMVP
PMV Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.26
+3.72%Oct 5, 2026, 13:02 UTC
PMV Pharmaceuticals, Inc. appointed Matthew Eckler as a director effective October 1, 2026, granting him an initial stock option award for 84,000 shares and an annual option to purchase 42,000 shares.
Aug 31, 2026, 20:02 UTC
PMV Pharmaceuticals announced the commencement of an underwritten public offering of common stock and warrants, including pre-funded warrants, to raise capital.
Aug 14, 2026, 12:00 UTC
PMV Pharmaceuticals reported its financial results for the second quarter ended June 30, 2026.
Source: